IP Verse

Genzyme patent opposition analysis

Get complete Patent Opposition Report for Genzyme

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Genzyme opposed by its competitors

Explore Genzyme's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3137497	Mar 5, 2025	Aav Vectors For Retinal And Cns Gene Therapy	1
EP2976359	Mar 23, 2022	Methods For Treating Osteogenesis Imperfecta	1
EP2970843	Sep 1, 2021	High-Density Cell Banking Methods	1
EP3047013	Aug 18, 2021	Methods And Systems For Processing A Cell Culture	1
EP3497207	Jan 6, 2021	Methods For Detecting Aav	2
EP3152299	Nov 20, 2019	Seed Train Processes And Uses Thereof	3
EP3133070	Aug 14, 2019	Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The Patient	3
EP2371361	Aug 7, 2019	Methods To Mobilize Progenitor/Stem Cells	14

Top competitors of Genzyme

ACCORD HEALTHCARE

TEVA PHARMACEUTICAL INDUSTRIES

BETAPHARM ARZNEIMITTEL